Cancer Therapeutics Biotherapeutic Market Forecast: Projecting the Global Impact of Biosimilar Penetration.
The Economic Tsunami of Biosimilars and Market Reconfiguration
The forecast for the cancer biotherapeutic market is heavily weighted by the anticipated wave of biosimilar competition following the patent expiration of several major blockbuster monoclonal antibodies. This entry of biosimilars is expected to trigger a significant price erosion (estimated to be between $20\%$ to $40\%$ per product...
0 Commenti
0 condivisioni
143 Views
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt